Why the study?
Does smoking cessation using nicotine replacement therapy improve cardiovascular risk factors and haemorheology parameters in male heavy smokers?
Population
197 males, aged 25-45 years, smoking >20 cigarettes per day.
Comparison
Nicotine replacement therapy for 12 weeks with… vs Control smokers who continued smoking.
Design
Cohort, Open
Follow-up
26 weeks
Authors
Loading...
Abstinence-linked haemorheologic gains in heavy smokers merit prospective trials; leaves open NRT effects in randomized settings.
Does smoking cessation using nicotine replacement therapy improve cardiovascular risk factors and haemorheology parameters in male heavy smokers?
Smoking cessation improves cardiovascular risk factors and haemorheology parameters, and the use of nicotine replacement therapy does not negate these benefits.
Haustein et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: